Filter
930
Text search:
testing
algorithm
Featured
Recommendations
140
New Publications
278
Language
Document type
No document type
533
Guidelines
187
Studies & Reports
111
Manuals
55
Strategic & Response Plan
16
Training Material
14
Fact sheets
6
Situation Updates
5
Infographics
2
Countries / Regions
India
64
South Africa
31
Kenya
29
Global
29
Ethiopia
27
Western and Central Europe
26
Tanzania
20
Nigeria
19
Zambia
19
Eastern Europe
17
Uganda
16
Nepal
16
Rwanda
16
Malawi
15
Namibia
14
Ghana
12
Philippines
11
Liberia
10
Bangladesh
10
Sierra Leone
9
Zimbabwe
9
Lesotho
9
East and Southern Africa
9
Latin America and the Carribbean
9
South–East Asia Region
8
Asia
8
Africa
8
Myanmar / Burma
7
West and Central Africa
7
Cambodia
5
Ukraine
5
Russia
5
Georgia
5
Cameroon
4
Indonesia
4
Botswana
4
Senegal
3
Pakistan
3
South Sudan
3
Eswatini/ Swaziland
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Tajikistan
3
Guinea
2
Afghanistan
2
Gambia
2
Sri Lanka
2
Bhutan
2
Armenia
2
Timor Leste/ East Timor
2
Moldova
2
Iran
2
Burkina Faso
1
Morocco
1
USA
1
Saudi Arabia
1
Iraq
1
Jordan
1
Lebanon
1
Syria
1
Mozambique
1
Sudan
1
Argentina
1
Brazil
1
North Macedonia
1
Colombia
1
El Salvador
1
Greece
1
Western Pacific Region
1
North Korea
1
Albania
1
Gabon
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Tunisia
1
United Kingdom
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
377
Clinical Guidelines
120
Women & Child Health
39
Public Health
28
Pharmacy & Technologies
25
Capacity Building
14
Key Resources
12
Toolboxes
HIV
151
TB
140
COVID-19
56
NTDs
43
Mental Health
30
AMR
30
Ebola & Marburg
22
Rapid Response
20
NCDs
19
Caregiver
15
Zika
14
2.0 Rapid Response
12
Malaria
9
Refugee
8
Disability
7
Pharmacy
7
Polio
6
Planetary Health
6
Cholera
3
Conflict
3
Global Health Education
3
Natural Hazards
2
Health Financing Toolbox
2
Specific Hazards
1
Accessed: 29.09.2019
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
Review Article
Granich et al. Int J Virol AIDS 2018, 5:043 DOI: 10.23937/2469-567X/1510043 Volume 5 | Issue 1
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit
...
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau
...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat
...
Health Policy Plan (2017) 32 (5): 603-612; 10 pp. 318 kB
Accessed: 28.03.2019
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition
...
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi
...
Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691
